跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,209 条关于
“Kartos Therapeutics”
全部
17,209
临床试验
4,065
药物
3,150
机构
1,162
资讯
8,832
2个月前
Ipsen Acquires Kartos Therapeutics for $450M to Develop Navtemadlin, an MDM2 Inhibitor for Myelofibrosis
上个月
Ipsen Upgrades 2026 Guidance on 23.5% Sales Growth, Positive Phase III Readouts, and Pipeline-Building Acquisitions
去年
FDA Approves Pemigatinib for Rare FGFR1-Rearranged Myeloid/Lymphoid Neoplasms Following Stanford-Led Phase II Trial
去年
CML Treatment Market Poised for Significant Growth Through 2032 Amid Wave of Recent FDA Approvals
去年
Kairos Pharma Advances Oncology Therapeutics with ENV105 in Clinical Trials
8个月前
Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics
去年
Keros Therapeutics Halts PAH Trial Following Safety Concerns with Cibotercept
3个月前
XRHealth Acquires Swing Therapeutics to Expand Digital Therapeutics Portfolio
去年
Valerio Therapeutics Expands Antibody Development Capabilities with Emglev Therapeutics Acquisition
4年前
Rise Therapeutics Advances Oral Immunotherapies Across Multiple Phase 1 Trials
第 1 页,共 884 页
上一页
下一页